As the complexity of clinical growt...

As the complexity of clinical growth grows and the market for modern medicines expands, it should originate as little surprise that clinical trials have become honestly global. The major drug increase regions of the world are primarily North America, Europe and Japan, still emerging markets such as those in Asia, Latin America, and Africa are playing a greater part in the global plans of pharmaceutical and biotech companies. This is illustrated on industry data showing that clinical trial spending in the Middle East and Africa rose from $10 billion (U dollars) in 1998 to $75 billion